Amit Ravindra Pantawane

Amit Ravindra Pantawane

Auto-generated profile, based on publicly available information

Amit Ravindra Pantawane

National Tsing Hua University, No. 101, Section 2, Kuang-Fu Road, Hsinchu City

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2021 in Catalysts
Verified
Journal Article
Open access
PDF file
APAmit Ravindra Pantawane
Amit Ravindra Pantawane
MTMayur Thul
Mayur Thul
YLYi-Jyun Lin
Yi-Jyun Lin
MLMichelle Lin
Michelle Lin
WLWesley Lin
Wesley Lin
SLShun-Yuan Luo
Shun-Yuan Luo
This report discloses a mild and efficient O-acetylation using easily accessible TMSOAc as a novel acetyl reagent and O-trimethylsilylation using HMDS for various alcohols catalyzed by tunable Brønsted acidic ionic liquids (TBAILs). Imidazolium-based TBAILs were prepared by a two-step atom-economic reaction and acidities measured by using UV-visible spectroscopy. Both protections for alcohols were accomplished at room temperature with good to excellent yields, while the products and TBAILs were separated by simple work-up for O-silylation and column chromatography for O-acetylation. Notably, with the simple post-process, TBAILs catalyst in this solvent free method easily recovered and recycled several times without significant degradation.

14 November 2026 in The Indonesian Biomedical Journal
Verified
Journal Article
Open access
PDF file
CHCandra D. Hamdin
Candra D. Hamdin
MGMursal Ghazali
Mursal Ghazali
PRPantawane Amit Ravindra
Pantawane Amit Ravindra
Reymund Callanga DeriloReymund Callanga Derilo
Reymund Callanga Derilo
VHVania Aisyah Aulia Syahda Haris
Vania Aisyah Aulia Syahda Haris
LSLalu Rudyat Telly Savalas
Lalu Rudyat Telly Savalas
BACKGROUND: Renovascular hypertension (RVH) drives excessive renin-angiotensin-aldosterone system (RAAS) activation, oxidative stress, and vascular remodelling, but most of current RVH therapies may not fully prevent the disease progression. Brucea javanica seed is known to contain bioactive compound that modulate RAAS and regulate blood pressure, but their effects on RVH remain unclear. This study was conducted to evaluate the potential of B. javanica seed extract (BJSE) as antihypertensive and renoprotective effects. METHODS: BJSE were profiled using liquid chromatography–high resolution mass spectrometry (LC-HRMS) and antioxidant activity was assessed. Network pharmacology and molecular docking were conducted to identify compound–protein targets. Male BALB/c mice was RVH-induced by renal blood flow restriction surgery and received either: no treatment, captopril, or, 10, 20, 30 mg/kg BW BJSE. Healthy mice were also included as control. Blood pressure, urinalysis, haematology, renal function, gross pathology, and kidney-heart histology were evaluated.RESULTS: Ten major metabolites were identified, including flavonoids, phenolic acids, and terpenoids. Antioxidant assays showed IC50 values of 71.81±0.35 ppm (DPPH), 76.30±0.29 ppm (FRAP), and 49.45±0.26 ppm (ABTS). Network pharmacology revealed five hub genes (matrix metallopeptidase 9 (MMP9), peroxisome proliferator-activated receptor gamma (PPARG), nitric oxide synthase 3 (NOS3), angiotensin-converting enzyme (ACE), estrogen receptor 1 (ESR1)), further molecular docking showed phloretin has the highest potential binding with ACE mapped to RAAS. BJSE dose-dependently reduced systolic blood pressure, proteinuria, blood urea nitrogen (BUN), and creatinine, improved erythrocyte parameters and leukocyte counts, and attenuated renal atrophy, cardiac hypertrophy, and histopathological lesions.CONCLUSION: BJSE significantly reduced blood pressure and improved cardiac and renal histopathological profiles, as well as hematological and urinary parameters associated with renoprotective activity. These effects are achieved suggested due to its antioxidant activity and multi-targeted mechanisms. KEYWORDS: polycystic ovary syndrome, Brucea javanica, network pharmacology, renin-angiotensin-aldosterone system, renovascular hypertension, two-kidney-one-clip

31 July 2025 in Synthesis
Verified
Journal Article
Closed access
PDF file
WHWen-Yueh Ho
Wen-Yueh Ho
APAmit Pantawane
Amit Pantawane
QTQiao Tsai
Qiao Tsai
MYMeng-Jie Yang
Meng-Jie Yang
SYSheng-Chieh Yen
Sheng-Chieh Yen
SLShun-Yuan Luo
Shun-Yuan Luo
Herein, we report a simple and efficient protocol for the deprotection of acetate and benzoate to alcohols, catalyzed by an imidazolium-based acid. Acetate groups were selectively removed while benzoate groups remained intact under mild conditions, and benzoate needed harsher conditions. Notably, this protocol was successfully employed for carbohydrate-building block synthesis in a one-pot strategy, was compatible with different ester protecting groups such as O-Bz, O-Ts, and O-Piv and site-selective deprotection of acetate. The reusable, environmentally benign catalyst enabled smooth operation, resulting in a promising protocol for deprotection.